Target intelligence / Profile preview

60S ribosomal protein L17 pseudogene

Molecular classification: Other (pseudogene), Processed pseudogene

Overview

60S ribosomal protein L17 pseudogene (ENSG00000218757) is a nonfunctional, processed pseudogene derived from the RPL17 gene, which encodes a structural component of the 60S ribosomal subunit[1][2][3]. Pseudogenes like this arise from reverse transcription and genomic integration of mRNA transcripts, often lacking protein-coding ability and regulatory functions[2][3][6]. While functional RPL17 plays a role in protein synthesis, the pseudogene does not contribute directly to cellular processes and is dispersed randomly throughout the genome[2][3][6]. There are no known disease associations or therapeutic applications for this pseudogene.

Other names: RPL17 pseudogeneRibosomal protein L17 pseudogene

Beyond the preview

Go deeper on 60S ribosomal protein L17 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 60S ribosomal protein L17 pseudogene.

Explore the full profile